Lee Wooin, Kim Richard B
Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA.
Annu Rev Pharmacol Toxicol. 2004;44:137-66. doi: 10.1146/annurev.pharmtox.44.101802.121856.
Carrier-mediated processes, often referred to as transporters, play key roles in the reabsorption and secretion of many endogenous and xenobiotic compounds by the kidney. The renal proximal tubule is the primary site of active transport for a wide variety of substrates, including organic anions/cations, peptides, and nucleosides. During the past decade, significant advances in molecular identification and characterization of transporter proteins have been made. Although it is generally noted that these transporters significantly contribute to renal drug handling and variability in drug disposition, the extent of our knowledge regarding the specific roles of such transporters in drug disposition and drug-drug interactions remains, for the most part, limited. In this review, we summarize recent progress in terms of molecular and functional characterization of renal transporters and their clinical relevance to drug therapy.
载体介导的过程,通常被称为转运体,在肾脏对许多内源性和外源性化合物的重吸收和分泌中起关键作用。肾近端小管是多种底物(包括有机阴离子/阳离子、肽和核苷)主动转运的主要部位。在过去十年中,转运蛋白的分子鉴定和表征取得了重大进展。尽管人们普遍认为这些转运体对肾脏药物处理以及药物处置的变异性有显著贡献,但我们对这些转运体在药物处置和药物-药物相互作用中具体作用的了解在很大程度上仍然有限。在这篇综述中,我们总结了肾转运体在分子和功能表征方面的最新进展及其与药物治疗的临床相关性。